B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 5,000 shares at $76.19 ($381K) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Scheduled sale ($381k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.19 | 4,466 | $340K | 89.2% |
| 2 | $76.97 | 534 | $41K | 10.8% |
| Total | $76.27 avg | 5,000 | $381K | 100% |
| Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |
| CYTK | SELL | 2025-11-19 | $324K | — | Filing → |